COVID: Germany – 28 Jan BBC Report that German Vaccine Committee A consultant to the German government stated that the company’s COVID-19 vaccine was given. Astraseneca From England, should not be over 65 years old
EPA
–
The said committee, which is an independent committee, argues that There is currently not enough information to evaluate the efficacy of astrazeneca vaccine in people 65 years of age and older, and it is recommended that the vaccine be given only to those 18-64 years old at each stage.
However, the British approved the Vaccine Astra Seneca – Oxford. Almost a month ago And injected people over 65 years old Dr. Mary Ramsay Vaccination head Public Health England said both the Vaccine AstraZenaga And Pfizer-BionTech It is safe and provides high levels of COVID-19 protection, especially against severe disease.
“There are very few cases among the elderly in the astrazeneca vaccine trial that observed the precise degree of protection among the elderly. But the immune system response data can assure its efficacy.
part Prime Minister Boris Johnson Given that he was not concerned with the advice of Germany. “Our own agency explicitly thought that the Atrazeneca-Oxford vaccine was good and very effective. Provides a high level of protection After a single injection … and the evidence given is thought to be effective for all age groups. ”
CNN
–
The movement of Germany occurs as European Union or EU Are having a dispute with Astra Seneca. After the EU signed an agreement with Astra Seneca in August last year. To buy 300 million doses of vaccine and the right to buy another 100 million doses
Astra Seneca said that Vaccine plants in the Netherlands and Belgium delayed production of vaccines. Therefore unable to deliver the EU according to the contract by Mr. Pascal Zoriot CEO Astra Seneca said the production of the vaccine normally needed two months.
But the EU said Astra Seneca must comply with the contract and deliver the vaccine. By gunstock vaccine from England And calls for serious action to ensure the vaccination
In addition Pfizer-Biontech Company The makers of the vaccine against COVID-19 American and German citizenship Reduce the number of doses delivered to the EU as well. After the EU signed an agreement to purchase 300 million doses of the vaccine.
Meanwhile European Medicines Committee It will decide on Friday, Jan. 29, whether to approve the vaccine AstraZeneca for use throughout the EU. By the EU hoping that Immediate delivery will begin, with 80 million doses of the vaccine arriving in the EU by March. But the problem of production delays makes hope flickering
The report states that Last week The EU will receive 60 percent of the vaccine, or about 50 million fewer doses than it promised in the first quarter of this year.
However, both the EU and Astra Seneca pledged to work together to resolve and negotiate the crisis on Wednesday, Jan. 27.
Related news:
COVID: EU Yuya “Astra Seneca” reduced the amount of vaccine delivered in time to produce!
–
